Tumor Microenvironment

Tumor microenvironment is the source’s name for the local immune-suppressive setting inside solid tumors in E235｜20年内CAR-T治愈癌症？与刘诚博士聊聊癌症治疗的底层哲学. [[LiuCheng|刘诚]] says blood circulation lacks the same level of suppressive environment, which helps explain why [[CARTCellTherapy|CAR-T]] has worked better in blood cancers than in solid tumors.

The episode presents the tumor microenvironment as unfriendly to immune cells. It can include immunosuppressive factors, regulatory T cells, and myeloid-derived suppressor cells, all of which can weaken or stop immune attack. For CAR-T, this means that even when engineered cells recognize a tumor antigen and enter the tumor, they may not remain functional long enough to clear the cancer.

Key Claims

• The tumor microenvironment can suppress immune-cell activity after engineered cells enter solid tumors.
• Reducing or bypassing local immune suppression is a major research direction in cancer treatment.
• The concept explains why Solid Tumor CAR-T Constraints are broader than antigen selection or cell dose alone.

Connections

• Solid Tumor CAR-T Constraints - main CAR-T context where the tumor microenvironment matters.
• CAR-T Cell Therapy and In Vivo CAR-T - therapies whose effectiveness depends on local immune function.
• Cancer Immune Recognition Problem - recognition must be paired with durable immune activity.
• Eureka Therapeutics - company context for solid-tumor CAR-T work in the source.